Immutep Limited
-
Ticker
IMMP
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 11-50 Employees
- Based in Sydney, Australia
Immutep is a globally active biotechnology company, listed on the Australian Stock Exchange and on the NASDAQ Global Market in the US. As a leader in personalized bio-therapeutic products for cancer, Immutep is dedicated to leveraging its current technology and expertise to develop innovative treatment options for patients and maximize value to shareholders.
Immutep Limited
Most Recent Annual Report
MOST RECENT
2021 Annual Report
Older/Archived Annual Reports